Crafting and executing the commercialization launch strategy for the innovative gene therapy products. Developing and implementing strategic initiatives to bring these cutting-edge treatments to market effectively. Collaborate with patient organizations to conduct educational programs aimed at enhancing patient understanding and awareness of these novel treatments. Creating educational materials, organizing seminars or workshops, and ensuring that patients and their families have access to accurate and up-to-date information about the gene therapy options available to them. Bridging the gap between scientific innovation and patient needs, facilitating informed decision-making and enhancing the overall patient journey.

Responsible for the promotion of rhNGF products (Cenegermin) in Eastern China, exceeded the regional sales target, and contributed to the forefront of the country.From August 2021 to February 2022, in charge of sales in the Eastern China Region, covering 5HC in five provinces of Jiangsu, Zhejiang, Shanghai, Fujian and Anhui, enhancing rhNGF's market visibility and sales.Planned and implemented a variety of marketing activities, effectively improved the willingness of ophthalmologists in the target region to prescribe rhNGF and achieved steady growth in the performance of the Eastern Region.

Responsible for the development and sales of the new anti-VEGF ophthalmic product Aflibercept in Nanjing, Suzhou, Wuxi, and Changzhou area, established and maintained good customer relations.Obtained the admission of more than 20 top Grade III hospitals in the region and established stable expert cooperation, rapidly increasing the MS of anti-VEGF in ophthalmology.Exceeded the regional Sales target and won the DIA BU 2019 Top Sales Award.

Promote the antibiotic product Ceftriaxone in Shanghai, Suzhou, and Changzhou, achieve continuous sales growth, and increase the MS.In-depth understanding of customer needs, providing professional product information and medication guidance for doctors and medical institutions, effectively improving the rational use rate of antibiotics.Completed the development of more than 20 target hospitals, covering more than 100 target customers, and won the 2018 Top Sales Award in the Eastern Region.